Abstract Details
|
PRESENTER |
No disclosure on file |
| Roy E. Strowd III, MD, FÂ鶹´«Ã½Ó³» (Wake Forest School Of Medicine) | Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³». The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care. |
| Barbara Agee Shah, NP (Pacific Neuroscience Medical Group) | No disclosure on file |
| Maria Corrada, PhD (University of California Irvine) | The institution of Dr. Corrada has received research support from NIH. |
| No disclosure on file | |
| Szofia S. Bullain, MD (F. Hoffmann - La Roche Ltd.) | Dr. Bullain has received personal compensation for serving as an employee of F. Hoffmann - La Roche Ltd.. Dr. Bullain has received stock or an ownership interest from F. Hoffmann - La Roche Ltd.. |
| Claudia Kawas, MD (University of California, Irvine) | The institution of Dr. Kawas has received research support from NIH. |